Learn languages naturally with fresh, real content!

Popular Topics
Explore By Region
ALK's peanut allergy treatment shows promise in early clinical trial, with plans for further testing.
ALK's clinical trial for a peanut allergy treatment showed positive results, with the sublingual immunotherapy tablet proving safe and tolerable in a trial of 30 patients.
Mild side effects were common but transient.
The next phase, involving about 125 patients, will test two dosing regimens and is set to conclude in 2026.
Success could lead to further development and potential approval for treating peanut allergies, which affect up to 1.5 million children and adolescents in the US.
3 Articles
El tratamiento de alergia a los cacahuetes de ALK muestra una promesa en un ensayo clínico temprano, con planes para realizar más pruebas.